This Article Full Text Full Text (PDF) All Versions of this Article: 119/17/2343    most recent CIRCULATIONAHA.108.805465v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chiam, P. T.L. Articles by Vitek, J. J. Search for Related Content PubMed PubMed Citation Articles by Chiam, P. T.L. Articles by Vitek, J. J. Related Collections Carotid Stenosis Angioplasty and Stenting Related Articles

(Circulation. 2009;119:2343-2348.)
© 2009 American Heart Association, Inc.

Interventional Cardiology

One-Year Clinical Outcomes, Midterm Survival, and Predictors of Mortality After Carotid Stenting in Elderly Patients

Paul T.L. Chiam, MBBS, MRCP; Gary S. Roubin, MD, PhD; Georgia Panagopoulos, PhD; Sriram S. Iyer, MD; Richard M. Green, MD; Christina Brennan, MD; Jiri J. Vitek, MD, PhD

From the Department of Cardiac and Vascular Interventional Services, Lenox Hill Heart and Vascular Institute, New York, NY (P.T.L.C., G.S.R., S.S.I., R.M.G., C.B., J.J.V.); Department of Cardiology, National Heart Center, Singapore (P.T.L.C.); and Department of Research, Lenox Hill Hospital, New York, NY (G.P.).

Correspondence to Gary S. Roubin, Lenox Hill Heart and Vascular Institute, 130 E 77th St, New York, NY 10021. E-mail groubin{at}lenoxhill.net

Received July 7, 2008; accepted February 11, 2009.

Background— It has been demonstrated recently that carotid stenting can be performed safely in patients 80 years of age. However, it is uncertain whether these patients will derive benefit because longevity after revascularization is an important consideration. This study was conducted to determine survival and predictors of mortality of selected elderly patients after stenting.

Methods and Results— One hundred forty-two consecutive elderly patients who were non–high risk for stenting underwent 153 procedures. Patients had either symptomatic stenosis 50% or asymptomatic stenosis 70%. Demographics and in-hospital outcomes were entered into a database; subsequent outcomes and mortality data were obtained retrospectively. Mean±SD age was 83.3±3.1 years. Symptomatic patients accounted for 28%. Overall survival at 3 years was 76% (85% at 2 years). At 1 year, 1 fatal stroke had occurred, with 97% of survivors (n=114) free of neurological events (neurological status was undetermined in the remaining 3%). Predictors of mortality were remote (6 months) transient ischemic attack or cerebrovascular accident, smoking history, and creatinine clearance (hemoglobin level showed a strong trend toward achieving significance); for the asymptomatic subgroup, predictors of mortality were smoking history, previous carotid endarterectomy, hemoglobin level, and increasing age. In particular, symptom status and sex were not independent predictors of mortality.

Conclusions— This study demonstrates that in selected elderly patients, a high proportion (85%) survived 2 years and >75% survived 3 years after stenting. Carotid stenting may be considered a revascularization option in such patients. Better selection of patients using the predictors of mortality may help to reduce unwarranted procedures and to optimize survival likelihood.

---

 

CLINICAL PERSPECTIVE

Related Articles:

Clinical Summaries
Circulation 2009 119: 2295-2296. [Extract] [Full Text]

Carotid Stenting in the Elderly: Is 80 the New 60?

Michael Belkin and Deepak L. Bhatt
Circulation 2009 119: 2302-2304. [Extract] [Full Text]

This article has been cited by other articles:

				Should Carotid Stenting Be Performed in Octogenarians? Journal Watch Cardiology, June 10, 2009; 2009(610): 4 - 4. [Full Text]

				M. Belkin and D. L. Bhatt Carotid Stenting in the Elderly: Is 80 the New 60? Circulation, May 5, 2009; 119(17): 2302 - 2304. [Full Text] [PDF]